Earnings Call · Q1 FY2021·2021-05-10

Q1 21EPS -54.17%·Rev n/aQ4 20EPS +9.62%·Rev n/aQ3 20EPS +100.00%*·Rev n/aQ2 20EPS +54.76%·Rev n/a⚠ consensus missing

SUPERNUS PHARMACEUTICALS, INC. SUPN

Peter Vozzo — Investor Relations Representative

Neil McFarlane — Chief Executive Officer

Vijay Shreedhar — Chief Commercial Officer

Chris Prentiss — Chief Financial Officer

+0.1%1d on move date3d+1.6%5d+5.4%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more SUPN calls or request research access.

More SUPN calls Browse calls Request research access